Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2010

Feb 22, 2010

284_dirs_2010-02-22_2d0c8703-4297-4278-bb03-5875fcbc3dcc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2010-02-19

Reporting Person: KOHAN RAUL E (Exe V-P & Pres, Animal Health)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-19 Restricted Stock Unit $0 A 21339 Acquired 2013-02-19 Common Stock (21339) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.